Sanofi’s Hemophilia A Drug Altuviiio Meets Primary Endpoint in Trial, Setting the Stage for EU Submission

Sanofi Distribution Centre in Kirkland, Quebec, Canada.

Sanofi’s Hemophilia A Drug Altuviiio Meets Primary Endpoint in Trial, Setting the Stage for EU Submission

03/02/2023

JHVEPhoto/iStock Editorial via Getty Images Sanofi (NASDAQ:SNY) said its hemophilia A therapy, Altuviiio, met the primary safety endpoint in a ...

Modern Medicine Research Laboratory: Diverse Team of Multi-Ethnic Young Scientists Passes Samples in Petri Dish. Advanced Lab with High-Tech Equipment, Microbiology Researchers Design, Develop Drugs

Aridis shares plunge ~25% as antibody drug fails Phase 3 trial in pneumonia

by Technical Terrence Team

01/26/2023

0

gorodenkoff Aridis Pharmaceuticals (NASDAQ:ARDS) AR-301 monoclonal antibody therapy failed the primary endpoint in a phase 3 trial to treat ventilator-associated ...

Headquarters of US Food and Drug Administration (FDA)

TScan shares jump ~15% with FDA go-ahead to begin cancer drug trials

by Technical Terrence Team

01/23/2023

0

Grandparents/iStock Editorial via Getty Images TScan Therapeutics (NASDAQ:TCRX) said the US Food and Drug Administration (FDA) has approved its investigational ...

type 2 diabetes doctor a test disease health medical concept

Oramed Stock Drops ~70% as Diabetes Drug Fails in Phase 3 Study

by Technical Terrence Team

01/12/2023

0

juststock/iStock via Getty Images Oramed Pharmaceutical' (NASDAQ:ORMP) the drug ORMD-0801 failed to meet the primary endpoint of improving blood sugar ...